David Katz is the president and chief investment officer of Matrix Asset Advisors, which he co-founded in 1986. Prior to co-founding Matrix, he worked at Management Asset Corp. in the research and portfolio management areas. At Matrix, Katz chairs the Investment Policy Committee.Expand

Katz is a CFA charterholder who appears frequently as a guest on CNBC, Bloomberg Television and Radio and WCBS-AM in New York. He graduated summa cum laude from Union College with a Bachelor of Arts degree in economics. He received a Master of Business Administration degree, with a concentration in finance, from New York University Graduate School of Business in 1987, graduating with distinction. His numerous works on value investing earned him various awards and distinctions at the undergraduate and graduate levels.Collapse

Staples Is a Value Trap Real Money Pro($)

It is not clear whether it has a perceived problem or a real one.
We can expect fundamentals and stock prices to improve further in the second half.
| Jul 18, 2014
| 10:31 AM EDT
COF quarter came in as we expected with an earnings beat of 2.06 vs. consensus of 1.82 and modest revenue beat...

Arguing Symantec Real Money Pro($)

Now is the time to buy.
| Jul 11, 2014
| 10:44 AM EDT
We haven't seen any follow up or analyst notes on the DealReporter Article from yesterday. In the absence of a...
It is preserving its Copaxone franchise, and the executive changes are good news.
| Jul 10, 2014
| 3:50 PM EDT
While we don't have the details of the story, we do like SYMC and believe that a takeover by a strategic or fi...

Playing Favorites Real Money Pro($)

We are doing our portfolio positioning for the second half of the year.

Coach Starts a Reset Year Real Money Pro($)

We're not buying yet. This may not be the bottom.

Avon Is a Stock for the Brave Real Money Pro($)

The valuation is very attractive but the challenges are daunting.  

Columnist Conversations

The semiconductor sector performed poorly today with the Market Vectors Semiconductor (SMH) fund down over 2% ...
Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Before: Transparency is...
ive tried to sense how these new rules can possibly be good for the mkt--and struck out trying. the investmen...
Skip Raschke and I have been talking about THIS behind the scenes. Note the following excerpt: "The rules also...

BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.